Elekta AB (publ), a medical technology company, provides clinical solutions for cancer and brain disorders worldwide. The company offers radiotherapy treatment systems, such as Versa HD, a dose delivery accuracy system; Elekta Infinity, an image-guided radiation therapy (IGRT) system; and Elekta Synergy, a digital accelerator for advanced IGRT. It also provides personalized imaging tools; automation and integration systems; beam shaping solutions; patient positioning and immobilization solutions; and radiotherapy treatment planning systems.
Elekta Fundamentals Summary
How do Elekta's earnings and revenue compare to its market cap?
Is EKTA B undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
5/6
Valuation Score 5/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
PEG Ratio
Key Valuation Metric
Which metric is best to use when looking at relative valuation for EKTA B?
Other financial metrics that can be useful for relative valuation.
The above table shows the n/a ratio for EKTA B. This is calculated by dividing EKTA B's market cap by their current
preferred multiple.
What is EKTA B's n/a Ratio?
n/a Ratio
0x
n/a
n/a
Market Cap
kr26.96b
EKTA B key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Earnings vs Industry: EKTA B is good value based on its Price-To-Earnings Ratio (23.4x) compared to the Swedish Medical Equipment industry average (36.5x)
Price to Earnings Ratio vs Fair Ratio
What is EKTA B's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
EKTA B PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio
23.4x
Fair PE Ratio
38.5x
Price-To-Earnings vs Fair Ratio: EKTA B is good value based on its Price-To-Earnings Ratio (23.4x) compared to the estimated Fair Price-To-Earnings Ratio (38.5x).
Share Price vs Fair Value
What is the Fair Price of EKTA B when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: EKTA B (SEK70.66) is trading below our estimate of fair value (SEK168.08)
Significantly Below Fair Value: EKTA B is trading below fair value by more than 20%.
Price to Earnings Growth Ratio
PEG Ratio: EKTA B is poor value based on its PEG Ratio (1.4x)
Discover undervalued companies
Future Growth
How is Elekta forecast to perform in the next 1 to 3 years based on estimates from 9 analysts?
Future Growth Score
3/6
Future Growth Score 3/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE
16.7%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: EKTA B's forecast earnings growth (16.7% per year) is above the savings rate (0.4%).
Earnings vs Market: EKTA B's earnings (16.7% per year) are forecast to grow faster than the Swedish market (9.6% per year).
High Growth Earnings: EKTA B's earnings are forecast to grow, but not significantly.
Revenue vs Market: EKTA B's revenue (7.6% per year) is forecast to grow faster than the Swedish market (5.5% per year).
High Growth Revenue: EKTA B's revenue (7.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: EKTA B's Return on Equity is forecast to be low in 3 years time (17%).
Discover growth companies
Past Performance
How has Elekta performed over the past 5 years?
Past Performance Score
2/6
Past Performance Score 2/6
Quality Earnings
Growing Profit Margin
Earnings Trend
Accelerating Growth
Earnings vs Industry
High ROE
10.4%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: EKTA B has high quality earnings.
Growing Profit Margin: EKTA B's current net profit margins (7.9%) are lower than last year (9.1%).
Past Earnings Growth Analysis
Earnings Trend: EKTA B's earnings have grown by 10.4% per year over the past 5 years.
Accelerating Growth: EKTA B's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: EKTA B had negative earnings growth (-8%) over the past year, making it difficult to compare to the Medical Equipment industry average (6.3%).
Return on Equity
High ROE: EKTA B's Return on Equity (13%) is considered low.
Discover strong past performing companies
Financial Health
How is Elekta's financial position?
Financial Health Score
6/6
Financial Health Score 6/6
Short Term Liabilities
Long Term Liabilities
Debt Level
Reducing Debt
Debt Coverage
Interest Coverage
Financial Position Analysis
Short Term Liabilities: EKTA B's short term assets (SEK12.9B) exceed its short term liabilities (SEK11.6B).
Long Term Liabilities: EKTA B's short term assets (SEK12.9B) exceed its long term liabilities (SEK5.8B).
Debt to Equity History and Analysis
Debt Level: EKTA B's net debt to equity ratio (17.2%) is considered satisfactory.
Reducing Debt: EKTA B's debt to equity ratio has reduced from 76.8% to 51.7% over the past 5 years.
Debt Coverage: EKTA B's debt is well covered by operating cash flow (40.3%).
Interest Coverage: EKTA B's interest payments on its debt are well covered by EBIT (10.5x coverage).
Balance Sheet
Discover healthy companies
Dividend
What is Elekta current dividend yield, its reliability and sustainability?
Dividend Score
4/6
Dividend Score 4/6
Notable Dividend
High Dividend
Stable Dividend
Growing Dividend
Earnings Coverage
Future Dividend Coverage
3.40%
Current Dividend Yield
Upcoming Dividend Payment
Dividend Yield vs Market
Notable Dividend: EKTA B's dividend (3.4%) is higher than the bottom 25% of dividend payers in the Swedish market (1.65%).
High Dividend: EKTA B's dividend (3.4%) is low compared to the top 25% of dividend payers in the Swedish market (5.33%).
Stability and Growth of Payments
Stable Dividend: EKTA B's dividend payments have been volatile in the past 10 years.
Growing Dividend: EKTA B's dividend payments have increased over the past 10 years.
Earnings Payout to Shareholders
Earnings Coverage: At its current payout ratio (79.5%), EKTA B's payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its high cash payout ratio (203.8%), EKTA B's dividend payments are not well covered by cash flows.
Discover strong dividend paying companies
Management
How experienced are the management team and are they aligned to shareholders interests?
5.4yrs
Average management tenure
CEO
Gustaf Salford (44 yo)
2yrs
Tenure
kr13,097,530
Compensation
Mr. Gustaf Salford serves as President and Chief Executive Officer at Elekta AB (publ) since November 26, 2020 and served as its Acting President and Chief Executive Officer since June 2, 2020 until Novemb...
CEO Compensation Analysis
Compensation vs Market: Gustaf's total compensation ($USD1.28M) is about average for companies of similar size in the Swedish market ($USD1.77M).
Compensation vs Earnings: Insufficient data to compare Gustaf's compensation with company performance.
Leadership Team
Experienced Management: EKTA B's management team is seasoned and experienced (5.4 years average tenure).
Board Members
Experienced Board: EKTA B's board of directors are seasoned and experienced ( 11.4 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: EKTA B insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Elekta AB (publ)'s employee growth, exchange listings and data sources
All financial data provided by Standard & Poor's Capital IQ.
Data
Last Updated (UTC time)
Company Analysis
2022/06/30 00:00
End of Day Share Price
2022/06/30 00:00
Earnings
2022/04/30
Annual Earnings
2022/04/30
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.